Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

47 Surgical Oncology P2

Download as pdf or txt
Download as pdf or txt
You are on page 1of 2

FINAL EXAM NATIONAL BOARD OF EXAMINATIONS

DECEMBER 2020
SURGICAL ONCOLOGY
PAPER-II
Time: 3 hours SURGONCO/D/20/47/II
Max. Marks:100
Important Instructions:
 You are provided with 5 answer sheet booklets. Each individual answer sheet booklet consists
of 10 pages excluding the covering jackets.
 Answers to all the questions must be attempted within these 5 answer sheet booklets which
must be later tagged together at the end of the exam.
 No additional supplementary answer sheet booklet will be provided.
 Attempt all questions in order.
 Each question carries 10 marks.
 Read the question carefully and answer to the point neatly and legibly.
 Do not leave any blank pages between two answers.
 Indicate the question number correctly for the answer in the margin space.
 Answer all the parts of a single question together.
 Start the answer to a question on a fresh page or leave adequate space between two answers.
 Draw table/diagrams/flowcharts wherever appropriate.

Write short notes on:


1. a) General principles in neoadjuvant therapy in rectal cancers. 5+5
b) Role of neo-adjuvant therapy in sphincter salvage.
2. a) What are the risk factors for endometrial cancers? 2+3+5
b) Molecular based classification of endometrial carcinoma.
c) Current evidence for minimal invasive surgery for carcinoma
endometrium.
3. a) Significance of HPV in head and neck cancers. 5+5
b) Difference in management and outcomes of HPV related squamous cell
carcinomas (HNSCC) of head and neck as compared to non HPV-
HNSCC.
4. Discuss Broncho-pulmonary segments. Write the current TNM staging for 3+3+4
lung cancer. Discuss the adjuvant treatment for a patient who underwent
surgery with tumor size 5 cms and a single N1 positive node.
5. a) Staging systems of Hepatoblastoma. 4+6
b) Management of Hepatoblastoma in Pediatric populations.
6. Work-up and management of carcinoma of an unknown primary. 5+5

7. a) Current status of tools available for risk assessment for adjuvant 5+5
therapy following surgery in breast cancer.
b) Assessment and work up of an asymptomatic 32 year old sister of a 35
year old patient with history of breast cancer in mother.
8. a) Discuss the options for limb salvage in a patient with locally advanced
synovial sarcoma of lower limb. 5+5
b) Briefly describe the options and factors affecting the management
decision for patient of synovial sarcoma presenting with a
metachronous pulmonary metastasis.
P.T.O.
-1-
POSSESSION/USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE
EXAMINATION HALL.
FINAL EXAM NATIONAL BOARD OF EXAMINATIONS
DECEMBER 2020
SURGICAL ONCOLOGY
PAPER-II

9. a) Mandibular reconstruction. 5+5


b) Management of anastomotic leak following esophagectomy.

10. a) Indications and regimes of chemotherapy for testicular tumors. 5+5


b) Types and indications of RPLND.

*************

-2-
POSSESSION/USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE
EXAMINATION HALL.

You might also like